| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 74,388 | 70,025 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 15,886 | 75,686 |
| Effect of exchange rate changes on cash | -26 | - |
| Cash and cash equivalents at beginning of period | 32,461 | - |
| Cash and cash equivalents at end of period | 48,321 | - |
Aura Biosciences, Inc. (AURA)
Aura Biosciences, Inc. (AURA)